Filing metadata

Accession number
0001140361-23-012884
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Mar 21, 2023
Reporting period
Mar 17, 2023
Description
Insider transaction

Explore SEC Filings Hub